Epstein-Barr Virus (EBV) Genomes and EBV-Encoded Latent Membrane Protein (LMP) in Pulmonary Lymphomas Occurring in Nonimmunocompromised Patients
Autor: | Jean-Christophe Sabourin, Marie-Claude Lescs, Elie Serge Zafrani, Panagiotis Kanavaros, Philippe Gaulard, Josette Brière, Tony Petrella |
---|---|
Rok vydání: | 1993 |
Předmět: |
Male
Herpesvirus 4 Human Pathology Lung Neoplasms medicine.disease_cause Lung Neoplasms/*immunology/microbiology/pathology immune system diseases hemic and lymphatic diseases Gammaherpesvirinae Antigens Viral In Situ Hybridization Immunodeficiency Viral Matrix Proteins/*analysis Lymphoma Non-Hodgkin Lymphoma T-Cell/immunology/microbiology/pathology Middle Aged medicine.anatomical_structure RNA Viral Immunohistochemistry Tumor Virus Infections/*immunology/pathology Anatomy Immunocompetence Adult medicine.medical_specialty Lymphoma B-Cell Biology Lymphoma T-Cell Virus Herpesviridae Immunophenotyping Pathology and Forensic Medicine Viral Matrix Proteins Immunocompromised Host medicine Humans Lymphoma B-Cell/immunology/microbiology/pathology neoplasms Aged Lung biology.organism_classification medicine.disease Epstein–Barr virus Lymphoma Tumor Virus Infections Antigens Viral/*analysis RNA Viral/analysis Lymphoma Non-Hodgkin/*immunology/microbiology/pathology Surgery Herpesvirus 4 Human/*isolation & purification |
Zdroj: | The American Journal of Surgical Pathology. 17:995-1002 |
ISSN: | 0147-5185 |
DOI: | 10.1097/00000478-199310000-00004 |
Popis: | Recently, in situ hybridization (ISH) techniques have shown that Epstein-Barr virus (EBV) could be detected in tumor cells of most angiocentric T-cell non-Hodgkin's lymphomas (NHL). These studies included only a few cases of T-NHL of the lung and pulmonary B-NHL and have not been investigated. Furthermore, the expression of the EBV-encoded latent membrane protein (LMP), which is known for its oncogenic properties, has not been reported. Twelve pulmonary NHL (six angiocentric T-NHL and six B-NHL) arising in nonimmunocompromised patients were examined for the presence of EBV-EBER mRNAs and LMP with ISH and immunohistochemistry, respectively. Four cases of pulmonary lymphomas arising in immunocompromised patients were also included in the study for comparison (one T-NHL in a patient under immunosuppressive treatment and three B-NHL in AIDS patients). EBV-RNA and LMP were detected in tumor cells in two of six nonimmunocompromised angiocentric T-NHL and in the four immunocompromised NHL. The six nonimmunocompromised B-NHL were EBV negative. These results suggest that EBV is associated with some angiocentric pulmonary T-NHL arising in patients without overt immunodeficiency whereas it is absent in such patients with B-NHL. The presence of the transforming EBV-encoded LMP in tumor cells suggests that EBV may be involved in the pathogenesis of some pulmonary T-NHL. Am J Surg Pathol |
Databáze: | OpenAIRE |
Externí odkaz: |